Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.6K Buy
1,868
+299
+19% +$5.96K ﹤0.01% 916
2026
Q1
$29.5K Sell
1,569
-93
-6% -$1.75K ﹤0.01% 879
2025
Q4
$26K Buy
1,662
+252
+18% +$3.74K ﹤0.01% 928
2025
Q3
$18.7K Buy
+1,410
New +$18.2K ﹤0.01% 877
2025
Q2
Sell
-809
Closed -$12.3K 920
2025
Q1
$12.3K Sell
809
-1,358
-63% -$20.3K ﹤0.01% 866
2024
Q4
$31.6K Sell
2,167
-261
-11% -$4.08K ﹤0.01% 690
2024
Q3
$38.8K Sell
2,428
-196
-7% -$3.48K ﹤0.01% 732
2024
Q2
$49.9K Buy
2,624
+270
+11% +$5.06K 0.01% 643
2024
Q1
$46K Sell
2,354
-540
-19% -$10K 0.01% 683
2023
Q4
$58.7K Sell
2,894
-800
-22% -$15.7K 0.01% 584
2023
Q3
$77.2K Sell
3,694
-224
-6% -$4.45K 0.01% 477
2023
Q2
$62.8K Sell
3,918
-320
-8% -$5.22K 0.01% 533
2023
Q1
$78.5K Buy
4,238
+40
+1% +$864 0.01% 473
2022
Q4
$87.7K Buy
4,198
+2,490
+146% +$52.3K 0.02% 439
2022
Q3
$28K Buy
1,708
+123
+8% +$2.07K 0.01% 674
2022
Q2
$27K Buy
1,585
+256
+19% +$4.82K 0.01% 658
2022
Q1
$26K Buy
1,329
+1,238
+1,360% +$21.7K ﹤0.01% 740
2021
Q4
$1K Buy
+91
New +$1.25K ﹤0.01% 1049

Other funds holding NOV

Quent Capital's NOV Position: Q2 2026 in Review

Quent Capital increased its NOV (NOV) stake by 19% in Q2 2026, buying an estimated $5.96K and bringing the position to 1,868 shares worth $34.6K. The position accounts for ﹤0.01% of the portfolio, ranked #916.

Quent Capital first reported a position in NOV in Q4 2021 and has held it in 18 quarters since. The position peaked at $87.7K in Q4 2022. 488 funds tracked by Wall St. Rank hold NOV as of Q2 2026.

  • Quent Capital held 1,868 shares of NOV worth $34.6K as of Q2 2026.
  • Quent Capital bought 299 NOV shares in Q2 2026, an estimated $5.96K.
  • NOV made up ﹤0.01% of Quent Capital's portfolio in Q2 2026, its #916 holding.
  • Quent Capital first reported a position in NOV in Q4 2021 and has held it in 18 quarters since.
  • Quent Capital's NOV position peaked at $87.7K in Q4 2022.
  • 488 funds tracked by Wall St. Rank held NOV as of Q2 2026.

Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.